ReviewSeminars in interventional radiology2017
Advances in the Medical Management of Vascular Anomalies.
Review in Seminars in interventional radiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 46 citations in OpenAlex.
- Are We Overlooking Vascular Anomalies in Oral and Maxillofacial Surgical Training?Journal of maxillofacial and oral surgery · 2025Article
- Application of Radiofrequency Ablation for the Treatment of Cutaneous Hemangioma and Vascular Malformation in a Cockscomb Model.Dermatology research and practice · 2025Article
- A report of 12 cases of congenital hepatic hemangioma and literature review.Frontiers in pediatrics · 2025Article
- The Role of Medical Management in Vascular Anomalies.Seminars in interventional radiology · 2024Review
- An imaging‑based diagnostic approach to vascular anomalies of the oral and maxillofacial region.Oncology letters · 2023Article
- Barriers to Genetic Testing in Vascular Malformations.JAMA network open · 2023Article
- Review of diagnosis, differential diagnosis, and management of retroperitoneal lymphangioma.Japanese journal of radiology · 2023Review
- Atlas of Nervous System Vascular Malformations: A Systematic Review.Life (Basel, Switzerland) · 2022Review
- Treatment of angiokeratomas of Fordyce with topical rapamycin 0.25% cream.JAAD case reports · 2021Article
- Giant Hepatic Hemangioma Regressed Significantly Without Surgical Management: A Case Report and Literature Review.Frontiers in medicine · 2021Article
- New and Emerging Targeted Therapies for Vascular Malformations.American journal of clinical dermatology · 2020Review
- A Primer on a Comprehensive Genetic Approach to Vascular Anomalies.Frontiers in pediatrics · 2020Review
- Use of Multispectral Optoacoustic Tomography to Diagnose Vascular Malformations.JAMA dermatology · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Vascular anomalies comprise a spectrum of diseases that are broadly classified as tumors and malformations. Diagnosis is often challenging, given a wide range of clinical presentations with overlapping signs and symptoms. Accurate diagnosis is critical to determine prognosis and to generate a management plan, which frequently involves multiple subspecialists during different phases of treatment. An updated classification system provides structure and clear, consistent terminology, allowing for improved diagnosis, provider communication, and collaboration. Historically, treatment of vascular anomalies was primarily surgical and medical therapies were limited or ineffective. Recent discoveries of pharmacologic agents effective in treating vascular anomalies have broadened our medical therapeutic options, limiting the need for unnecessary or high-risk procedures and improving patients' quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.